Biofarm.dk ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.7% 16.8% 20.4% 7.3% 15.9%  
Credit score (0-100)  15 12 6 35 12  
Credit rating  BB BB B BBB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3

Net sales  0 0 0 0 0  
Gross profit  -187 885 -290 994 1,021  
EBITDA  -189 343 -688 660 210  
EBIT  -189 343 -688 660 210  
Pre-tax profit (PTP)  -191.7 177.5 -831.8 540.7 21.5  
Net earnings  -191.7 177.5 -638.7 421.7 16.0  
Pre-tax profit without non-rec. items  -192 177 -832 541 21.5  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  358 536 -103 319 335  
Interest-bearing liabilities  179 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  649 2,351 2,548 2,832 3,449  

Net Debt  179 -93.3 -60.9 -137 -74.7  
 
See the entire balance sheet

Volume 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -187 885 -290 994 1,021  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 2.8%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  649 2,351 2,548 2,832 3,449  
Balance sheet change%  0.0% 262.2% 8.4% 11.2% 21.8%  
Added value  -188.7 342.8 -688.0 660.2 209.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 1.0 2.0  

Profitability 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  101.1% 38.8% 237.5% 66.4% 20.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -29.1% 22.9% -27.5% 24.1% 6.7%  
ROI %  -35.1% 26.6% -37.6% 36.1% 9.9%  
ROE %  -53.5% 39.7% -41.4% 29.4% 4.9%  

Solidity 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3
Equity ratio %  55.2% 22.8% -3.9% 11.3% 9.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -94.9% -27.2% 8.9% -20.7% -35.6%  
Gearing %  50.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  3.3% 184.5% 0.0% 0.0% 0.0%  

Liquidity 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3
Quick Ratio  0.8 1.4 0.5 2.2 0.3  
Current Ratio  2.2 7.5 2.5 3.5 2.7  
Cash and cash equivalent  0.1 93.3 60.9 136.9 74.7  

Capital use efficiency 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  358.3 2,035.7 1,524.6 2,029.6 2,191.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2017/3
2017
2018/3
2018
2019/3
2019
2020/3
2020
2021/3
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 105  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 105  
EBIT / employee  0 0 0 0 105  
Net earnings / employee  0 0 0 0 8